Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd
Expert Review of Hematology | March 9, 2020 | Volume: 13 | Issue: 4 | Pages: 421-433
10.1080/17474086.2020.1729734
| PMID 32148109